These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 16552236

  • 1. Recent advances in head and neck cancer therapy: the role of new cytotoxic and molecular-targeted agents.
    Caponigro F, Milano A, Basile M, Ionna F, Iaffaioli RV.
    Curr Opin Oncol; 2006 May; 18(3):247-52. PubMed ID: 16552236
    [Abstract] [Full Text] [Related]

  • 2. Emerging drugs for head and neck cancer.
    Rhee JC, Khuri FR, Shin DM.
    Expert Opin Emerg Drugs; 2004 May; 9(1):91-104. PubMed ID: 15155138
    [Abstract] [Full Text] [Related]

  • 3. Molecular targeted therapy of head and neck cancer: review and clinical development challenges.
    Le Tourneau C, Faivre S, Siu LL.
    Eur J Cancer; 2007 Nov; 43(17):2457-66. PubMed ID: 17904355
    [Abstract] [Full Text] [Related]

  • 4. Targeting epidermal growth factor receptor in head and neck cancer: lessons learned from cetuximab.
    Moon C, Chae YK, Lee J.
    Exp Biol Med (Maywood); 2010 Aug; 235(8):907-20. PubMed ID: 20562132
    [Abstract] [Full Text] [Related]

  • 5. Emerging molecular targeted therapies in the treatment of head and neck cancer.
    Bozec A, Peyrade F, Fischel JL, Milano G.
    Expert Opin Emerg Drugs; 2009 Jun; 14(2):299-310. PubMed ID: 19519286
    [Abstract] [Full Text] [Related]

  • 6. Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck.
    Le Tourneau C, Siu LL.
    Curr Opin Oncol; 2008 May; 20(3):256-63. PubMed ID: 18391623
    [Abstract] [Full Text] [Related]

  • 7. Epidermal growth factor receptor directed therapy in head and neck cancer.
    Choong NW, Cohen EE.
    Crit Rev Oncol Hematol; 2006 Jan; 57(1):25-43. PubMed ID: 16207530
    [Abstract] [Full Text] [Related]

  • 8. Developing targeted therapies for lung cancer.
    Gandara DR.
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):648-9, 690. PubMed ID: 16258461
    [No Abstract] [Full Text] [Related]

  • 9. New targets for non-small-cell lung cancer therapy.
    Alvarez M, Roman E, Santos ES, Raez LE.
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1423-37. PubMed ID: 17944567
    [Abstract] [Full Text] [Related]

  • 10. Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial.
    Rivera F, García-Castaño A, Vega N, Vega-Villegas ME, Gutiérrez-Sanz L.
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1421-8. PubMed ID: 19828002
    [Abstract] [Full Text] [Related]

  • 11. Targeting epidermal growth factor receptor: novel therapeutics in the management of cancer.
    Khalil MY, Grandis JR, Shin DM.
    Expert Rev Anticancer Ther; 2003 Jun; 3(3):367-80. PubMed ID: 12820779
    [Abstract] [Full Text] [Related]

  • 12. Targeting angiogenesis in head and neck cancer.
    Seiwert TY, Cohen EE.
    Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
    [Abstract] [Full Text] [Related]

  • 13. [Combination therapy with molecular targeting drugs for head and neck cancer].
    Fujii M.
    Gan To Kagaku Ryoho; 2008 May; 35(5):740-4. PubMed ID: 18487910
    [Abstract] [Full Text] [Related]

  • 14. Targeted therapy in head and neck cancer.
    Licitra L, Bergamini C, Mirabile A, Granata R.
    Curr Opin Otolaryngol Head Neck Surg; 2011 Apr; 19(2):132-7. PubMed ID: 21372717
    [Abstract] [Full Text] [Related]

  • 15. A review on the treatment of relapsed/metastatic head and neck cancer.
    Ferrari D, Codecà C, Fiore J, Luciani A, Foa P.
    Expert Opin Pharmacother; 2009 Nov; 10(16):2625-32. PubMed ID: 19708856
    [Abstract] [Full Text] [Related]

  • 16. Emerging molecular targeted therapies in squamous cell carcinoma of the head and neck.
    Gilbert J, Argiris A.
    Clin Adv Hematol Oncol; 2006 Aug; 4(8):611-9. PubMed ID: 17099619
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy.
    Ang KK, Andratschke NH, Milas L.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):959-65. PubMed ID: 14967456
    [Abstract] [Full Text] [Related]

  • 19. Targeting epidermal growth factor receptor signaling in the treatment of head and neck cancer.
    Astsaturov I, Cohen RB, Harari P.
    Expert Rev Anticancer Ther; 2006 Sep 01; 6(9):1179-93. PubMed ID: 17020453
    [Abstract] [Full Text] [Related]

  • 20. The emerging role of cetuximab in head and neck cancer: a 2007 perspective.
    Panikkar RP, Astsaturov I, Langer CJ.
    Cancer Invest; 2008 Feb 01; 26(1):96-103. PubMed ID: 18181051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.